Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
J Clin Gastroenterol ; 55(9): 815-820, 2021 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-33060436

RESUMO

BACKGROUND: Vitamin D has anti-inflammatory and immune regulatory functions. GOALS: The authors investigated the effect of vitamin D supplementation in children with inflammatory bowel disease (IBD) and hypovitaminosis D on disease activity, quality of life (QOL), inflammatory markers, and cytokines. STUDY: This randomized double-blinded controlled clinical trial included 120 children with IBD and hypovitaminosis D; 22 of them were excluded later. Patients were randomized to receive either oral vitamin D3 in a dose of 2000 IU/day or placebo for 6 months. The primary outcome was to evaluate the effect of vitamin D supplementation on the IBD activity score. The secondary outcomes were to assess the QOL, inflammatory markers, cytokines, the safety of vitamin D, and to correlate serum vitamin D level with various clinical and laboratory variables. RESULTS: Vitamin D supplementation significantly decreased the IBD activity score in the vitamin D group compared with the placebo group. Moreover, QOL significantly improved after vitamin D supplementation. Inflammatory markers, for example, erythrocyte sedimentation rate, C-reactive protein, and fecal calprotectin and interleukin-2 IL-12, IL-17, IL-23, and tumor necrosis factor-alpha significantly decreased in the vitamin D group. However, IL-10 significantly increased after vitamin D supplementation. Vitamin D was significantly inversely correlated with the activity score, QOL score, levels of all inflammatory markers, the frequency of hospitalization, and emergency department visits. CONCLUSION: Vitamin D supplementation may have a beneficial effect in children with IBD.


Assuntos
Doenças Inflamatórias Intestinais , Deficiência de Vitamina D , Criança , Colecalciferol , Suplementos Nutricionais , Método Duplo-Cego , Humanos , Doenças Inflamatórias Intestinais/tratamento farmacológico , Qualidade de Vida , Vitamina D , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/tratamento farmacológico
2.
J Oral Maxillofac Surg ; 78(6): 908-915, 2020 06.
Artigo em Inglês | MEDLINE | ID: mdl-32087119

RESUMO

PURPOSE: Although concerns regarding implant-related metal hypersensitivity exist, no guidelines have been accepted for screening or treatment of patients with metal sensitivity before temporomandibular joint replacement (TMJR). The present study aimed to determine the trends in TMJR metal sensitivity screening and the effect of positive test results on patient treatment. MATERIALS AND METHODS: A questionnaire was distributed to members of the American Society of Temporomandibular Joint Surgeons and the European Society of Temporomandibular Joint Surgeons using a web-based data collection and analysis tool. The questions aimed to establish the screening methods used to establish a diagnosis of metal hypersensitivity and any changes in management when metal hypersensitivity had been documented. RESULTS: A total of 72 responses (32.43%) were collected through the survey, with respondents primarily practicing in the United States (47.22%). Of the participants, 75% believed that metal hypersensitivity occurs with TMJR and only 2.77% did not. Most agreed that patients should be questioned about any metal sensitivities before consideration for TMJR (91.66%), and 80.55% routinely asked their patients if they had a previous sensitivity to any metals. Nickel was the most commonly encountered metal allergen (64.28%). If a metal allergy were reported, 44.28% of surgeons would refer the patient to determine the specific metal allergen. The diagnosis for metal allergy was based primarily on patient signs and symptoms (52.85%) and an allergist or dermatologist consultation (44.28%). The lymphocyte transformation test was the test most used by respondents to confirm the diagnosis. Of the surgeons, 41.42% would choose to observe/monitor as their first choice for patients testing positive for metal hypersensitivity. In the case of a "mild" reaction to metal hypersensitivity testing, 54.28% would alter their implant choice to a nonreactive metal component. For "severe" reactions to preoperative metal hypersensitivity testing, 62.85% would alter their implant choice to a nonreactive metal component, and 22.85% would choose not to perform TMJR. CONCLUSIONS: The results from the present study have demonstrated that respondent TMJ surgeons agree that metal hypersensitivity occurs with TMJR. However, their approaches to screening and managing metal hypersensitivity vary. Further research of this topic is required to eventually develop specific management pre- and postoperative guidelines for the treatment of patients with metal sensitivities.


Assuntos
Artroplastia de Substituição , Implantes Dentários , Hipersensibilidade , Prótese Articular , Humanos , Metais , Articulação Temporomandibular/cirurgia
3.
J Pediatr Gastroenterol Nutr ; 66(6): 882-886, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29287013

RESUMO

OBJECTIVES: The aim of the study was to assess the accuracy of the inferior vena cava to aorta (IVC/Ao) diameter ratio for predicting significant dehydration in infants relative to their percentage weight change and the clinical diagnosis by a physician. METHODS: A prospective observational study was performed on 200 infants presented with acute diarrhea and clinical evidence of significant dehydration whose treatment required intravenous (IV) fluids as determined by the attending physician at the pediatric emergency department of Tanta University Hospital. Weight was recorded at admission before IV fluid treatment and at hospital discharge. The percentage of dehydration was determined using the following formula: (discharge weight - admission weight)/discharge weight × 100%. Patients with a percentage weight change of <5% were considered to be nonsignificantly dehydrated, whereas patients with a percentage weight change >5% were considered significantly dehydrated. The IVC/Ao diameter ratio was measured for all patients before IV fluid rehydration and again at discharge. RESULTS: Only 134 out of 200 dehydrated infants were found to be significantly dehydrated using the gold standard, percentage weight change. Receiver operating characteristics (ROC) curve analysis of the prehydration IVC/Ao ratio showed a sensitivity of 82%, a specificity of 91%, and an accuracy of 87% for predicting significant dehydration in infants at a cut-off point of less than 0.75. In contrast, physician clinical diagnosis showed a sensitivity of 70%, a specificity of 63%, and an accuracy of 73%. CONCLUSIONS: The IVC/Ao diameter ratio can be used as a reliable predictor for diagnosing significant dehydration in infants.


Assuntos
Aorta/diagnóstico por imagem , Desidratação/diagnóstico por imagem , Diarreia/complicações , Veia Cava Inferior/diagnóstico por imagem , Determinação do Volume Sanguíneo , Desidratação/etiologia , Desidratação/fisiopatologia , Feminino , Humanos , Lactente , Masculino , Testes Imediatos , Estudos Prospectivos , Sensibilidade e Especificidade , Ultrassonografia
4.
J Pediatr Gastroenterol Nutr ; 67(3): 346-350, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-29620595

RESUMO

OBJECTIVE: The aim of the study was to evaluate the frequency and type of pulmonary dysfunction in newly diagnosed children with inflammatory bowel disease (IBD) and the correlation between pulmonary function tests (PFTs) and IBD activity. METHODS: It is an observational case-control study. One hundred newly diagnosed children with IBD were enrolled as the patient group, which was further subdivided into 52 with Crohn disease (CD) and 48 with ulcerative colitis (UC). Fifty healthy children matched for age, sex, height, and body mass index (BMI) served as the control group. PFTs in the form of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), FEV1/FVC, residual volume (RV), total lung capacity (TLC), mid-forced expiratory flow of 25% to 75% (FEF 25%-75%) and diffusing capacity of the lung for carbon monoxide (DLCO) were evaluated in all studied children. PFTs were measured at diagnosis, every 6 months for a period of 3 years, during remission and at least once during activity in patient group. RESULTS: There was significant progressive deterioration in all PFTs in IBD patients compared with their PFTs at the start of the study (P < 0.05) except for FEV1/FVC, RV, and TLC (P > 0.05). There was significant deterioration during disease activity compared with remission state as regards FEV1, FVC, FEF 25% to 75%, and DLCO (P < 0.05). Significant negative correlation was found between disease activity in both UC and CD groups and FEV1, FVC, FEF 25% to 75%, and DLCO. CONCLUSIONS: Subclinical PFTs abnormalities are common in pediatric IBD even during remission period. So, periodic PFTs evaluation should be considered in the routine follow-up of IBD children.


Assuntos
Doenças Inflamatórias Intestinais/epidemiologia , Pneumopatias/epidemiologia , Pneumopatias/fisiopatologia , Adolescente , Estudos de Casos e Controles , Criança , Comorbidade , Egito/epidemiologia , Feminino , Seguimentos , Humanos , Estudos Longitudinais , Masculino , Estudos Prospectivos , Testes de Função Respiratória/métodos
5.
J Biosci ; 492024.
Artigo em Inglês | MEDLINE | ID: mdl-38173317

RESUMO

Helicobacter pylori infection is a prevalent global infection associated with several complications such as peptic ulcer, upper gastrointestinal bleeding, and stomach cancer. An imbalance in the gut microbiota composition or the relationship between the microbiota and the host may be implicated in the infection. To investigate this, we studied the intestinal microbiota of 50 newly infected adolescents with H. pylori compared with 50 age-matched and sex-matched healthy controls. The gut microbiota composition was assessed using real-time polymerase chain reaction (RT-PCR), and the fecal bacterial diversity and composition were compared between groups. Our findings revealed that Clostridium difficile and Salmonella spp. were significantly higher in the patient group compared to the control group. Additionally, lower counts of eubacteria, Bacteroides fragilis, Lactobacillus spp., Escherichia coli, and Methanobrevibacter smithii, were observed in the gut of adolescents with H. pylori. Conversely, adolescents with H. pylori infection had non-significantly higher counts of Bifidobacterium spp., C. difficile, and Salmonella spp. Multiple logistic regression analysis revealed that a greater abundance of Bifidobacterium spp. and Salmonella spp., a higher prevalence of C. difficile, and a lower abundance of Lactobacillus spp. were predictive of H. pylori infection. Overall, our results suggest that H. pylori infection is associated with changes in fecal microbiome composition.


Assuntos
Clostridioides difficile , Microbioma Gastrointestinal , Infecções por Helicobacter , Helicobacter pylori , Humanos , Adolescente , Infecções por Helicobacter/genética , Infecções por Helicobacter/microbiologia , Helicobacter pylori/genética , Microbioma Gastrointestinal/genética , Fezes/microbiologia , Escherichia coli
6.
Pediatr Infect Dis J ; 39(3): 192-196, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-31764377

RESUMO

BACKGROUND: The aim of this study was to evaluate the pulmonary function test (PFT) abnormalities, if any, in children with newly diagnosed chronic hepatitis B (CHB) infection over 3 years. METHODS: This is an observational case-control study. One hundred children and adolescents with newly diagnosed CHB were enrolled as the patient group that was further subdivided into 2 groups (50 patients each): inactive carriers (group I) and patients in immunotolerant phase (group II). Only 90 patients completed the study. Fifty healthy children of matched age, sex and height served as a control group, only 45 of them completed the study. PFTs in the form of forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), FEV1/FVC, residual volume, total lung capacity, mid-forced expiratory flow of 25%-75% and diffusing capacity of the lung for carbon monoxide were evaluated in all studied children at the start, yearly and at the end of the study after 3 years. Liver function tests were also evaluated. RESULTS: There was a significant progressive decrease in FEV1, FVC, forced expiratory flow, total lung capacity and diffusing capacity of the lung for carbon monoxide in CHB patient groups compared with their pulmonary functions at the start of the study and with the control group (P < 0.05), while FEV1/FVC and residual volume showed nonsignificant change (P > 0.05). CONCLUSIONS: Subclinical PFT abnormalities are present in children with CHB more than we expected. So, PFT monitoring is recommended in pediatric patients with CHB.


Assuntos
Vírus da Hepatite B , Hepatite B Crônica/complicações , Hepatite B Crônica/virologia , Pneumopatias/complicações , Pneumopatias/fisiopatologia , Estudos de Casos e Controles , Criança , Egito/epidemiologia , Feminino , Hepatite B Crônica/epidemiologia , Humanos , Pneumopatias/diagnóstico , Masculino , Vigilância em Saúde Pública , Testes de Função Respiratória/métodos
7.
J Saudi Heart Assoc ; 30(3): 198-204, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-29983495

RESUMO

OBJECTIVE: Heart failure (HF) is a progressive disorder in children. Many HF biomarkers have been identified to assess its severity and predict its course. The aim of this study was to evaluate the prognostic value of plasma levels of homocysteine (HCY) and highly sensitive cardiac troponin T (hs-cTnT) in children with HF. MATERIALS AND METHODS: Eighty children with acute HF were enrolled in this study as the patient group and 80 healthy children of matched age and sex served as the control group. HCY and hs-cTnT serum levels were measured before and after HF treatment; additionally, echocardiographic examinations were performed before and after therapy. All patients were followed up for 3 months. RESULTS: Plasma levels of HCY and hs-cTnT were significantly higher in children with HF before treatment, compared with their levels in children with HF after treatment and with the control group. This increase in serum levels of both biomarkers was associated with increased severity of HF according to the Ross classification of HF. HCY had higher specificity, positive predictive value, and accuracy than hs-cTnT. Serum levels of both biomarkers had a significant positive correlation with cardiomegaly and a significant negative correlation with left ventricular ejection fraction and fraction shortening. Marked elevation of both serum biomarkers was significantly associated with poor outcome with mortality rate of 10%. CONCLUSION: Plasma HCY and serum hs-cTnT levels have a good prognostic value in children with congestive heart failure (CHF) and their levels significantly correlated with clinical and echocardiographic data, severity of HF, and adverse outcome in children with CHF.

8.
Saudi J Gastroenterol ; 24(2): 109-114, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29637918

RESUMO

Background/Aim: Vitamin D deficiency is common in irritable bowel syndrome (IBS). There is growing interest in the role of vitamin D in pediatric IBS. We aimed to evaluate the effect of vitamin D supplementation in adolescents with IBS and vitamin D deficiency. Patients and Methods: One hundred and twelve adolescents with IBS and vitamin D deficiency were randomly divided into two groups of matched age and sex. The first group received oral vitamin D3 2000IU/day for 6 months and the second group received placebo for 6 months. Vitamin D status as well as different IBS score systems (IBS-SSS, IBS-QoL, and total score) were evaluated before and 6 months after treatment. Results: IBS patients who received vitamin D supplementation for 6 months showed significant improvement in IBS-SSS (P < 0.001), IBS-QoL (P < 0.001), and total score (P = 0.02) compared to IBS placebo group. IBS patients treated with vitamin D showed two folds increase in their serum vitamin D levels (from 17.2 ± 1.3 to 39 ± 3.3) ng/ml with P < 0.001. While in the placebo group, their serum vitamin D levels were not significantly changed (P = 0.66). Vitamin D was tolerated well without any recorded adverse effects during the study period. Conclusion: Vitamin D supplementation can be effective in treating adolescents with IBS and vitamin D deficiency.


Assuntos
Síndrome do Intestino Irritável/tratamento farmacológico , Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/administração & dosagem , Administração Oral , Adolescente , Suplementos Nutricionais , Feminino , Humanos , Masculino , Estudos Prospectivos , Resultado do Tratamento , Vitamina D/uso terapêutico
9.
J Am Heart Assoc ; 6(3)2017 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-28249845

RESUMO

BACKGROUND: Postoperative junctional ectopic tachycardia is one of the most serious arrhythmias that occur after pediatric cardiac surgery, difficult to treat and better to be prevented. Our aim was to assess the efficacy of prophylactic dexmedetomidine in preventing junctional ectopic tachycardia after pediatric cardiac surgery. METHODS AND RESULTS: A prospective controlled study was carried out on 90 children who underwent elective cardiac surgery for congenital heart diseases. Patients were randomized into 2 groups. Group I (dexmedetomidine group): 60 patients received dexmedetomidine; Group II (Placebo group): 30 patients received the same amount of normal saline intravenously. The primary outcome was the incidence of postoperative junctional ectopic tachycardia. Secondary outcomes included bradycardia, hypotension, vasoactive inotropic score, ventilation time, pediatric cardiac care unit stay, length of hospital stay, and perioperative mortality. The incidence of junctional ectopic tachycardia was significantly reduced in the dexmedetomidine group (3.3%) compared with the placebo group (16.7%) with P<0.005. Heart rate while coming off cardiopulmonary bypass was significantly lower in the dexmedetomidine group (130.6±9) than the placebo group (144±7.1) with P<0.001. Mean ventilation time, and mean duration of intensive care unit and hospital stay (days) were significantly shorter in the dexmedetomidine group than the placebo group (P<0.001). However, there was no significant difference between the 2 groups as regards mortality, bradycardia, or hypotension (P>0.005). CONCLUSION: Prophylactic use of dexmedetomidine is associated with significantly decreased incidence of postoperative junctional ectopic tachycardia in children after congenital heart surgery without significant side effects.


Assuntos
Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Dexmedetomidina/administração & dosagem , Cardiopatias Congênitas/cirurgia , Frequência Cardíaca/efeitos dos fármacos , Complicações Pós-Operatórias/prevenção & controle , Taquicardia Ectópica de Junção/prevenção & controle , Agonistas de Receptores Adrenérgicos alfa 2/administração & dosagem , Relação Dose-Resposta a Droga , Eletrocardiografia , Feminino , Humanos , Lactente , Infusões Intravenosas , Masculino , Estudos Prospectivos , Taquicardia Ectópica de Junção/etiologia , Taquicardia Ectópica de Junção/fisiopatologia , Resultado do Tratamento
10.
Infect Disord Drug Targets ; 16(1): 54-62, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26715443

RESUMO

BACKGROUND: Infection 'is a common complication in children with hematological malignancies' during febrile neutropenia. ' OBJECTIVE: The aim of this study was to' evaluate common bacterial and fungal pathogens in children with hematological malignancies during febrile neutropenia in single center Egyptian study. ' PATIENTS AND METHODS: This study was carried out on 90' children with hematological malignancies during febrile neutropenia including 54 with ALL, 27 with AML and 9 with NHL with their ages ranging from 2.5- 13 years and mean age value of 5.5 ± 3.5. Complete blood count, BM aspiration, and blood and throat cultures were done for all patients. RESULTS: Positive bacterial growth was found in 54 cultures (30%) including 42 blood cultures and 12 throat cultures with significantly higher Gram negative bacterial growth. Staphylococcus aurous and Pseudomonas aeruginosa were the most common Gram positive and negative organisms respectively. Cefepime was the most effective antibiotic against isolated bacterial growth where 80% of Gram negative bacterial growth was sensitive to it, 20% showed intermediate response and no Gram negative Cefepime resistance was recorded. On the other hand, 62.5% of Gram positive organisms was sensitive to it, 25% showed intermediate response and Gram positive Cefepime resistance was found in 12.5%. Ampicillin sulbactam 'was the most effective antibiotic against Gram positive' organisms with 100% sensitivity. Positive fungal growth was found in 36 cultures (20%) including 30 throat cultures and 6 blood cultures and all fungal isolates were candida. Amphotericin was active against 100% of fungal isolates, while resistance to Fluconazole and Voriconazole was found in 25% and 33.33% respectively. CONCLUSIONS: 'Gram negative is still more common than gram positive' infections and fungal infection is also a common cause of fever in patients with hematological malignancies during neutropenia and must be taken in consideration in every case of febrile neutropenia.


Assuntos
Neutropenia Febril/microbiologia , Fungos/isolamento & purificação , Bactérias Gram-Negativas/isolamento & purificação , Neoplasias Hematológicas/microbiologia , Adolescente , Ampicilina/farmacologia , Antibacterianos/farmacologia , Antifúngicos/farmacologia , Bacteriemia , Contagem de Células Sanguíneas , Candida/efeitos dos fármacos , Candida/isolamento & purificação , Cefepima , Cefalosporinas/farmacologia , Criança , Pré-Escolar , Egito/epidemiologia , Neutropenia Febril/epidemiologia , Feminino , Fungos/efeitos dos fármacos , Fungos/crescimento & desenvolvimento , Fungos/patogenicidade , Bactérias Gram-Negativas/efeitos dos fármacos , Bactérias Gram-Negativas/crescimento & desenvolvimento , Bactérias Gram-Negativas/patogenicidade , Humanos , Masculino , Faringe/microbiologia , Pseudomonas aeruginosa/efeitos dos fármacos , Pseudomonas aeruginosa/isolamento & purificação , Pseudomonas aeruginosa/patogenicidade , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/isolamento & purificação , Staphylococcus aureus/patogenicidade
11.
Mediterr J Hematol Infect Dis ; 8(1): e2016008, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26740869

RESUMO

BACKGROUND: Acute lymphoblastic leukemia (ALL) is the most common childhood cancer representing 23% of pediatric cancers. Wilms' tumor -1 gene is a novel prognostic factor, minimal residual disease marker and therapeutic target in acute leukemia. AIM OF THE WORK: The aim of this work was to study the impact of WT-1 gene expression in the prognosis of ALL. PATIENTS AND METHODS: This study was conducted on 40 Egyptian children with newly diagnosed ALL who were subjected to full history taking, thorough clinical examination and laboratory investigations including; complete blood count, LDH, BM aspiration, cytochemistry, immunophenotyping, FISH technique for detection of t(12;21) and t(9;22) and assessment of WT-1 Gene by real-time PCR in BM samples at time of diagnosis. RESULTS: Positive WT-1 gene expression was found in 22 cases (55%) and negative expression in 18 cases (45%). Positive WT-1 gene expression group (n=22) includes 14 males and 8 females with mean age at presentation of 5.261 ± 0.811 while negative WT-1 gene expression group (n=18) includes 12 males and 6 females with mean age at diagnosis of 9.669 ± 3.731 with significantly older age in negative WT-1 gene expression group but no significant differences between positive and negative WT-1 gene expression groups regarding sex and clinical presentations. There were no significant differences in platelets and WBCs counts, hemoglobin and LDH levels and the number of peripheral blood and BM blast cells at diagnosis between positive and negative WT-1 gene expression groups but after induction therapy there were significantly lower BM blast cells in positive WT-1 gene expression group. There were no statistically significant differences between positive and negative WT-1 gene expression groups regarding immunophenotyping and chromosomal translocations including t(12;21) and t(9;22). There were a significantly higher relapse and death rate and a lower rate of CR, DFS, and OAS in negative WT-1 gene expression group. MRD at end of induction therapy was found in 14 cases out of 40 patients. There were significantly higher number of patients with MRD+ in negative WT-1 gene expression group (After the therapy 20 out of 22 (89%) patients with positive WT-1 gene expression attained a negative MRD, while only 6 out of 18 (33%) with negative WT-1 attained a negative MRD) (p-value = 0.006). CONCLUSIONS AND RECOMMENDATION: WT-1 gene expression is an important prognostic factor in patients with ALL, being able to prognosticate a negative MRD. Therefore, we can recommend its incorporation into novel risk-adapted therapeutic strategies in patients with ALL.

12.
Infect Disord Drug Targets ; 15(1): 64-71, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25809628

RESUMO

BACKGROUND: 'Acute lymphoblastic leukemia is the most common childhood malignancy'. Adding methotrexate to treatment protocols increased survival rate in children with leukemia. Methotrexate efficacy is limited by its hepatotoxicity. AIM OF THE STUDY: To assess the therapeutic value of Black seed oil in 'methotrexate induced hepatotoxicity in Egyptian children with acute lymphoblastic leukemia'. SUBJECTS AND METHODS: This study was conducted on 40 children with acute lymphoblastic leukemia' including 20 patients under methotrexate therapy and Black seeds 80 mg/kg/day for one week after each methotrexate dose [Group II] and 20 patients under methotrexate therapy and placebo [Group III]. This study included also '20 healthy children of matched age and sex as a control group' [Group I]. All patients were subjected to complete blood picture, bone marrow aspiration and liver functions. RESULTS: No significant differences in liver functions between group II and III before therapy were observed. There were nonsignificant increase in total, direct and indirect serum bilirubin, serum ALT, AST, and alkaline phosphatase levels and prothrombin time in group II after methotrexate and Black seed oil therapy but there was significant increase in group III after treatment with methotrexate and placebo with 'significant differences between group II and III ' after therapy. There were significant differences in prognosis regarding remission, relapse, death and 'disease free survival but no significant difference in overall survival between group II and III'. CONCLUSION: Black cumin seeds decreased MTX hepatotoxicity and improved survival in children with ALL and can be recommended as adjuvant drug in patients with ALL under methotrexate therapy.


Assuntos
Antimetabólitos Antineoplásicos/efeitos adversos , Doença Hepática Induzida por Substâncias e Drogas/prevenção & controle , Cuminum/química , Fígado/efeitos dos fármacos , Metotrexato/efeitos adversos , Óleos de Plantas/uso terapêutico , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Adolescente , Antimetabólitos Antineoplásicos/uso terapêutico , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Leucovorina/administração & dosagem , Fígado/metabolismo , Masculino , Metotrexato/uso terapêutico , Óleos de Plantas/administração & dosagem , Óleos de Plantas/química , Leucemia-Linfoma Linfoblástico de Células Precursoras/complicações , Prognóstico , Sementes/química
13.
Arch Pathol Lab Med ; 132(2): 244-7, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-18251584

RESUMO

CONTEXT: Diagnostic detection of tuberculosis (TB) has improved considerably. Available, standardized, nucleic acid-based amplification techniques have been shown to yield reliable results within 4 to 7 hours of sample processing. OBJECTIVE: To study the diagnostic performance of Gen-Probe's technique for direct detection of Mycobacterium tuberculosis in comparison with BACTEC 460 TB culture for both positive and negative Ziehl-Neelsen smears in Egyptian children at risk for TB infection. DESIGN: We prospectively evaluated 50 children from families with a positive history of TB. All patients were referred from outpatient clinics of the Mansoura University Children's Hospital, Egypt. The children had a positive tuberculin skin test with an induration diameter of more than 10 mm and had scars from a bacille Calmette-Guérin vaccination within the past 2 years. Three consecutive sputum samples were taken from each patient. The samples were examined to detect M. tuberculosis by means of the Gen-Probe technique, direct smear microscopy, and bacterial culture by BACTEC 460 TB. RESULTS: Of the 50 cases, 30 (60%) had sputum samples that were positive for TB by BACTEC 460 TB culture, and 29 cases (58%) were positive by the Gen-Probe technique. Sensitivity and specificity of Ziehl-Neelsen smears was 83.3% and 100%, respectively, with overall accuracy of 90%. Sensitivity and specificity of the Gen-Probe technique were 96.7% and 100%, respectively, with overall accuracy of 98%. CONCLUSIONS: The results of this study suggest that the Gen-Probe technique is an accurate method for rapid detection of M. tuberculosis complexes in respiratory samples from children at risk for TB. It can be used for diagnosis of smear-negative cases that are suspect for TB.


Assuntos
Mycobacterium tuberculosis/isolamento & purificação , Tuberculose Pulmonar/diagnóstico , Tuberculose Pulmonar/microbiologia , Adolescente , Técnicas Bacteriológicas , Criança , Sondas de DNA/química , Egito , Feminino , Amplificação de Genes , Humanos , Masculino , Mycobacterium tuberculosis/genética , Mycobacterium tuberculosis/crescimento & desenvolvimento , Estudos Prospectivos , RNA Bacteriano/análise , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Escarro/microbiologia , Teste Tuberculínico
14.
Hematology ; 11(4): 261-6, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-17178665

RESUMO

This study was carried out to detect Parvovirus B19 (PB19) DNA together with its antibodies in the sera of children with a range of hematological disorders to clarify the contribution of this infection to changes observed in hematological picture in those populations. This study included 85 pediatric patients with different hematological disorders. Twenty healthy subjects with matched age and sex were included as controls. Patients were classified into four groups; group I included 25 patients with hemolytic anemia in aplastic crisis, group II included 20 patients with hemolytic anemia without aplastic crisis, group III included 20 acute leukemia patients under chemotherapy, group IV included 20 patients with recently diagnosed acute leukemia. Virological study for PB19 included determination of specific IgG & IgM together with viral DNA by polymerase chain reaction (PCR). In all groups of patients with positive markers for PB19, there were statistically significant differences in the mean Hb concentration and RBC count (P < 0.001 for each), presence of neutropenia (P = 0.003) and lymphocytosis (P < 0.001) compared to controls. There was statistically significant difference in the prevalence of PB19 IgM, IgG and PCR among studied groups compared to control group. In group I and group II IgG had the highest positive rate (56 and 35%, respectively). In group III IgG also had a high positive rate (45%). However, in group IV IgM had the highest positive rate (50%) followed by PCR (45%) then IgG (40%). In conclusion, PB19 infection is detected in high rates among children with hematological disorders. PB19 must be suspected and screened for when there is anemia in those patients associated with neutropenia and lymphocytosis. In patients with acute leukaemia under chemotherapy who have unexpected anemia, neutropenia and lymphocytosis Parvovirus infection should be considered before a change of chemotherapy protocol. Screening of blood for PB19 may be helpful in understanding the epidemiology of infection with this virus. The direct detection of DNA by PCR in sera needs to be coupled with serology for a more reliable diagnosis of PB19 infections in these children.


Assuntos
Doenças Hematológicas/epidemiologia , Infecções por Parvoviridae/epidemiologia , Parvovirus B19 Humano/isolamento & purificação , Anemia Aplástica/epidemiologia , Anemia Aplástica/virologia , Anemia Hemolítica/epidemiologia , Anemia Hemolítica/virologia , Anticorpos Antivirais/sangue , Criança , Convalescença , DNA Viral/sangue , Egito/epidemiologia , Feminino , Doenças Hematológicas/virologia , História Medieval , Humanos , Imunoglobulina G/sangue , Imunoglobulina M/sangue , Leucemia/epidemiologia , Leucemia/virologia , Linfocitose/epidemiologia , Linfocitose/virologia , Masculino , Neutropenia/epidemiologia , Neutropenia/virologia , Infecções por Parvoviridae/sangue , Infecções por Parvoviridae/virologia , Parvovirus B19 Humano/genética , Parvovirus B19 Humano/imunologia , Parvovirus B19 Humano/patogenicidade , Reação em Cadeia da Polimerase , Prevalência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA